117 related articles for article (PubMed ID: 37105317)
21. Comparison of 1-h with 3-h planar
Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N
Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186
[TBL] [Abstract][Full Text] [Related]
22. Description of a different quantification method for amyloid burden (DPDload) and validation of SPECT/CT in cardiac amyloidosis.
Mallón Araujo MDC; Abou Jokh Casas E; Abou Jokh Casas C; Aguade Bruix S; Ruibal Morell Á; Pubul Núñez V
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(3):171-177. PubMed ID: 36796676
[TBL] [Abstract][Full Text] [Related]
23. Reliability and feasibility of visual grading systems and quantitative indexes on [
Bae S; Gil J; Paeng JC; Park EA; Lee SP; Choi H; Kang KW; Cheon GJ; Lee DS
Sci Rep; 2022 Oct; 12(1):17271. PubMed ID: 36241893
[TBL] [Abstract][Full Text] [Related]
24. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
[TBL] [Abstract][Full Text] [Related]
25. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
[TBL] [Abstract][Full Text] [Related]
26. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.
Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C
Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082
[TBL] [Abstract][Full Text] [Related]
27. Early-phase myocardial uptake intensity of
Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
[TBL] [Abstract][Full Text] [Related]
28. Deep Learning-Enabled Quantification of
Miller RJH; Shanbhag A; Michalowska AM; Kavanagh P; Liang JX; Builoff V; Fine NM; Dey D; Berman DS; Slomka PJ
J Nucl Med; 2024 May; ():. PubMed ID: 38724278
[TBL] [Abstract][Full Text] [Related]
29. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
30. SPECT/CT SUV-based metrics: A promising diagnostic tool in classifying patients with suspected transthyretin cardiac amyloidosis among the different Perugini grades?
Koukouraki S; Kapsoritakis N; Bourogianni O; Stathaki M; Zaganas I; Patrianakos A; Plevritaki A; Korela D; Marketou M; Foukarakis E
Hell J Nucl Med; 2023; 26(3):172-180. PubMed ID: 38085832
[TBL] [Abstract][Full Text] [Related]
31. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
[TBL] [Abstract][Full Text] [Related]
32. Correlation of Quantitative
Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
Heart Lung Circ; 2022 Jun; 31(6):804-814. PubMed ID: 35181228
[TBL] [Abstract][Full Text] [Related]
33. Assessment of cardiac amyloidosis with
Ren C; Ren J; Tian Z; Du Y; Hao Z; Zhang Z; Fang W; Li F; Zhang S; Hsu B; Huo L
EJNMMI Phys; 2021 Jan; 8(1):3. PubMed ID: 33411102
[TBL] [Abstract][Full Text] [Related]
34. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications.
Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY
Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903
[TBL] [Abstract][Full Text] [Related]
35. Correlation Between Quantitative Uptake of
Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
Front Cardiovasc Med; 2021; 8():663929. PubMed ID: 34722650
[No Abstract] [Full Text] [Related]
36. New quantitative indices of cardiac amyloidosis with
Matsuda N; Otsuka H; Otani T; Azane S; Kunikane Y; Otomi Y; Ueki Y; Kubota M; Amano M; Yagi S; Sata M; Harada M
Jpn J Radiol; 2023 Apr; 41(4):428-436. PubMed ID: 36449252
[TBL] [Abstract][Full Text] [Related]
37. AL-Type Amyloidosis Involving Stomach and Lungs in 99m Tc-DPD Bone Scan.
Lee Y; Yoo IR; O JH
Clin Nucl Med; 2022 Dec; 47(12):1059-1060. PubMed ID: 35835133
[TBL] [Abstract][Full Text] [Related]
38. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
40. Absolute Quantitation of Cardiac
Dorbala S; Park MA; Cuddy S; Singh V; Sullivan K; Kim S; Falk RH; Taqueti VR; Skali H; Blankstein R; Bay C; Kijewski MF; Di Carli MF
J Nucl Med; 2021 May; 62(5):716-722. PubMed ID: 32887756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
